Get started
Author

Xiangao Jiang

Observed names: Jiang Xian-gao, Xian-Gao Jiang, Xian-gao Jiang, Xian‐Gao Jiang
Observed institutions: Shanghai University, Wenzhou Medical University, Courant Institute of Mathematical Sciences, Wenzhou Central Hospital, New York University, Columbia University
ORCID: 0009-0005-9631-0015
Observed ORCID: 0009-0005-9631-0015
OpenAlex ID: A5112756992
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
2020 · Xiao-Wei Xu, Xiao-Xin Wu, et al. · BMJ · 2,068
PDF
Towards an Artificial Intelligence Framework for Data-Driven Prediction of Coronavirus Clinical Severity
2020 · Xiangao Jiang, Megan Coffee, et al. · Computers, materials & continua/Computers, materials & continua (Print) · 454
Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors
2020 · Rongfeng Qi, Wei Chen, et al. · medRxiv · 95
PDF
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
2020 · Jichan Shi, Yang Li, et al. · BMC Medicine · 92
PDF
COVID‐19 in tuberculosis patients: A report of three cases
2020 · Guiqing He, Jing Wu, et al. · Journal of Medical Virology · 87
PDF
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
2023 · Xiaohong Fan, Xiahong Dai, et al. · The Lancet Infectious Diseases · 51
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study
2018 · Feng Sun, Yang Li, et al. · European Respiratory Journal · 36
Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial
2022 · Zhi-Min Zhao, Chuan-Wu Zhu, et al. · Journal of Ethnopharmacology · 32
PDF
Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract
2022 · Guiqing He, Lianpeng Wu, et al. · Annals of Medicine · 26
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients
2022 · Jichan Shi, Guiqing He, et al. · Tuberculosis · 22
ZNRF3 contributes to the growth of lung carcinoma via inhibiting Wnt/β-catenin pathway and is regulated by miR-93
2015 · Jichan Shi, Xiangao Jiang, et al. · Tumor Biology · 21
Synergistic anti-inflammatory effect of cascade nanozymes for neural recovery in ischemic stroke
2025 · Chenchen Xie, Jun Liao, et al. · Chinese Chemical Letters · 17
Differential diagnosis for suspected cases of coronavirus disease 2019: a retrospective study
2020 · Qiong Chi, Xinjian Dai, et al. · BMC Infectious Diseases · 14
PDF
Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19
2021 · Zhenmu Jin, Mo Zheng, et al. · Frontiers in Molecular Biosciences · 12
PDF
Short-course Regimen for Subsequent Treatment of Pulmonary Tuberculosis: A Prospective, Randomized, Controlled Multicenter Clinical Trial in China
2018 · Liping Yan, Xiaohong Kan, et al. · Clinical Therapeutics · 11
N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
2023 · Fang Cheng, Xian-Gao Jiang, et al. · Frontiers in Pharmacology · 10
Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis
2024 · Xiaoxiao Cai, Xueqin Xu, et al. · BMC Infectious Diseases · 9
PDF
Clinical Manifestations, Imaging Features, and Treatment Follow-up of 29 Cases With Hepatic Tuberculosis
2022 · Saiduo, Wei, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 9
PDF
The diagnosis of leptospirosis complicated by pulmonary tuberculosis complemented by metagenomic next-generation sequencing: A case report
2022 · Jichan Shi, Wenjie Wu, et al. · Frontiers in Cellular and Infection Microbiology · 8
PDF
The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis
2022 · Jichan Shi, Gexin Gao, et al. · Infection and Drug Resistance · 8
PDF
Incidence, causes, and risk factors for unplanned readmission in patients admitted with pulmonary tuberculosis in China
2023 · Xinchun Ye, Xiaoqiao Su, et al. · The Journal of Infection in Developing Countries · 7
PDF
The Diagnostic Value of the Thermostatic Amplification of Ribonucleic Acid in Bronchoalveolar Lavage Fluid in Smear-Negative Pulmonary Tuberculosis
2022 · Zhengxing Wu, Jichan Shi, et al. · Frontiers in Public Health · 7
PDF
Study on the clinical efficacy and safety of baloxavir marboxil tablets in the treatment of influenza A
2024 · Chaochao Qiu, Fang Cheng, et al. · Frontiers in Medicine · 6
PDF
Trends in Drug Resistance and Epidemiological Patterns of Tuberculosis in Elderly Patients in Wenzhou, China (2014-2023)
2025 · Lianpeng Wu, Xiyue Cai, et al. · Infection and Drug Resistance · 5
PDF
Effectiveness and Safety of Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir in the Treatment of Moderate to Severe COVID‐19
2025 · Xin Chen, Xiao‐Qing Lin, et al. · Immunity Inflammation and Disease · 5
PDF
Works count: 50
Citation count: 3,151
H-index: 13
I10-index: 16
Year
Topic
Type